GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Research & Development

Purple Biotech (XTAE:PPBT) Research & Development : ₪63.70 Mil (TTM As of Dec. 2023)


View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Purple Biotech's Research & Development for the three months ended in Dec. 2023 was ₪19.60 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was ₪63.70 Mil.

Purple Biotech Research & Development Historical Data

The historical data trend for Purple Biotech's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech Research & Development Chart

Purple Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.52 27.07 44.23 61.03 63.70

Purple Biotech Quarterly Data
Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.03 13.08 13.86 17.16 19.60

Purple Biotech Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪63.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Purple Biotech  (XTAE:PPBT) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Purple Biotech Research & Development Related Terms

Thank you for viewing the detailed overview of Purple Biotech's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » Research & Development
Comparable Companies
XTAE:GFC-M XTAE:EVGN XTAE:BONS XTAE:DNA XTAE:CBI XTAE:MTLF XTAE:CANF XTAE:BOLT XTAE:SLGN XTAE:KDST OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
PPBT:USA 1YI1:Germany
Address
4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104
Website
https://www.purple-biotech.com
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.